SCHEMBL7962015

SCHEMBL7962015

Clc1ccc(OC[C@H]2CO2)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
GLA P06280 1/20 0.49
TDP1 Q9NUW8 3/20 0.47
TSHR P16473 2/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
S1PR4 O95977 4/20 0.45
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
DRD4 P21917 3/20 0.42
DRD2 P14416 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7962011 1.00 ALDH1A1 (0.49) ALDH1A1GLATDP1TSHRTP53
SCHEMBL2338368 1.00 ALDH1A1 (0.49) ALDH1A1GLATDP1TSHRTP53
SCHEMBL29847389 1.00 ALDH1A1 (0.49) ALDH1A1GLATDP1TSHRTP53
SCHEMBL2230996 0.89 TTR (0.45) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL30161198 0.89 TTR (0.45) ALDH1A1GLATSHRTP53CYP3A4
SCHEMBL9840397 0.87 KDM4E (0.44) ALDH1A1GLATDP1TSHRSMN1; SMN2
SCHEMBL2337120 0.86 ALDH1A1 (0.49) ALDH1A1GLATDP1TSHRTP53
SCHEMBL9803136 0.85 ALDH1A1 (0.59) ALDH1A1GLATDP1TSHRTP53
SCHEMBL2122103 0.83 ALDH1A1 (0.46) ALDH1A1GLATDP1TSHRTP53
SCHEMBL4294711 0.83 ALDH1A1 (0.46) ALDH1A1GLATDP1TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed